STOCK TITAN

PREMIER BIOMEDICAL (BIEI) Stock News, Dec 2022-Mar 2024

BIEI OTC

Welcome to our dedicated page for PREMIER BIOMEDICAL news (Ticker: BIEI), a resource for investors and traders seeking the latest updates and insights on PREMIER BIOMEDICAL stock.

Premier Graphene Inc. (BIEI) reports developments tied to graphene-based advanced materials, defense applications, and Mexico-focused commercial partnerships. The company describes its business as the development, supply, and brokerage of graphene and graphene-enhanced products for industrial, security, and defense-related uses, including protective-wear and armor-related technologies.

Recurring news themes include contract awards and operational updates involving Mexico’s defense supply chain, joint venture activity with HGI Industrial Technologies SAPI, and regulatory and licensing developments for industrial hemp and cannabinoid products in Mexico. Company updates also discuss graphene production from sustainable sources, advanced carbon materials, and cross-border manufacturing and distribution arrangements with Mexican affiliates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
30%
Tags
none
-
Rhea-AI Summary

Nova Graphene Ballistics, Inc. (OTC PINK: BIEI) is initiating the development of proprietary technology for lightweight, protective ballistic plates utilizing CarbonEra™ graphene. This involves enhancements such as 3D printing filaments, customized printer modifications, and a unique plate architecture. The prototype will be delivered to DARPA as part of their focus on military and law enforcement applications. CEO Gabe Vlad highlighted the product's integration capabilities with local networks for power and data. The company has also reorganized to eliminate convertible debt instruments, ensuring minimal dilution for shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Nova-Graphene Ballistics, Inc. (BIEI) has acquired rights to produce lightweight graphene ballistic plates in the U.S. using a new low-cost methodology, positioning itself as a key player in the electric vehicle and defense sectors. Graphene, known for its exceptional strength and conductivity, is predicted to revolutionize industries including medicine, semiconductors, and personal safety. The company has engaged in a reorganization to eliminate convertible debt, ensuring minimal shareholder dilution. With a focus on innovative 3D-printed armor, Nova-Graphene aims to enhance protection for military and law enforcement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.89%
Tags
none

FAQ

What is the current stock price of PREMIER BIOMEDICAL (BIEI)?

The current stock price of PREMIER BIOMEDICAL (BIEI) is $0.0005 as of September 11, 2026.

What is the market cap of PREMIER BIOMEDICAL (BIEI)?

The market cap of PREMIER BIOMEDICAL (BIEI) is approximately 824.9K.